ArticleClinicoEconomics and outcomes research : CEOR2021

Budgetary Impact of Bendamustine Ready-to-Dilute Products in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma to a United States Infusion Facility.

Elizabeth James et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.